| Literature DB >> 33287760 |
Martin van der Heide1, Mirthe J Mebius2, Arend F Bos2, Marcus T R Roofthooft3, Rolf M F Berger3, Jan B F Hulscher4, Elisabeth M W Kooi2.
Abstract
BACKGROUND: Necrotizing enterocolitis (NEC) is a devastating disease that is relatively frequently diagnosed in term infants with congenital heart disease (CHD), compared with term infants without CHD, in whom NEC is rare. The exact pathogenesis of NEC in term infants with CHD is unknown, but it is hypothesized that ischemia of the intestines plays a pivotal role. We aimed to explore whether (near) term CHD infants, who develop NEC, exhibit more clinical signs of hypoxia/ischemia and low body perfusion directly after birth and during the first 48 hours after admission to the neonatal intensive care unit, when compared with (near) term CHD infants who did not develop NEC.Entities:
Keywords: (near) term infants; Apgar score; Necrotizing enterocolitis; congenital heart disease; diastolic blood pressure; hypoxic/ischemic hits
Mesh:
Year: 2020 PMID: 33287760 PMCID: PMC7722324 DOI: 10.1186/s12887-020-02446-6
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1Flow diagram of the study. CHD: congenital heart disease. NEC: necrotizing enterocolitis
Type of CHD and Bell stage for infants with NEC and their matched controls
| NEC | Control | |
|---|---|---|
| Bell stage | Type of CHD | Type of CHD |
| 3B | Tetralogy of Fallot | Tetralogy of Fallot |
| 3B | IAA, DORV and AVSD | IAA, PFO, VSD and small aortic valve |
| 3B | Pulmonary valve stenosis | Pulmonary valve stenosis |
| 2A | Tetralogy of Fallot with pulmonary atresia | Tetralogy of Fallot with pulmonary atresia |
| 2A | TGA with DORV, VSD and PFO | TGA with DORV, VSD and tricuspid insufficiency |
| 3B | TGA with VSD | TGA with VSD |
| 3B | TGA with AVSD and small LV | TGA with VSD and ASD |
| 2A | IAA with VSD | IAA with VSD |
| 2A | IAA with VSD | IAA with VSD and hypoplastic aortic valve |
| 2B | CoA with TGA, hypoplastic aortic arch, DORV, VSD and ASD | CoA with hypoplastic aortic arch, DORV, VSD and ASD |
| 3B | TGA | TGA |
| 2B | Tetralogy of Fallot | Tetralogy of Fallot |
| 2B | TGA with DORV and VSD | TGA with DORV and VSD |
| 2A | CoA with VSD | CoA with VSD |
| 2A | CoA with hypoplastic aortic arch, VSD and ASD | CoA with hypoplastic aortic arch and VSD |
| 2B | TGA with VSD | TGA with VSD |
IAA interrupted aortic arch, DORV double outlet right ventricle, AVSD atrioventricular septal defect, PFO patent foramen ovale, VSD ventricular septal defect, TGA transposition of the great arteries, LV left ventricle, ASD atrial septal defect, CoA Coarctation of the aorta
Baseline characteristics
| NEC ( | Control ( | ||
|---|---|---|---|
| Sex (male) (%) | 9 (56) | 9 (56) | 1.00 |
| Gestational age (weeks) | 38.6 ± 1.9 | 39.1 ± 1.7 | 0.37 |
| Head circumference (cm)a | 33.5 (33.0–36.0) | 34.6 (32.0–37.0) | 0.25 |
| Birth weight (grams) | 2937 ± 701 | 3323 ± 546 | 0.14 |
| Small for gestational age status (%) | 5 (31) | 1 (6) | 0.07 |
| Percentiles of birth weight | 27 (1–58) | 41 (20–77) | 0.22 |
| Inborn (%) | 10 (63) | 9 (56) | 0.72 |
| Caesarian section (%) | 6 (38) | 2 (13) | 0.22 |
| Mother’s milk (%)b | 0 (0–0) | 7 (0–39) | 0.18 |
| Amount of feeding (ml/kg)b | 15 (8–20) | 23 (11–37) | 0.33 |
| Antenatal diagnosis of CHD (%) | 8 (50) | 9 (56) | 0.72 |
| Age at admission to NICU (days) | 0 (0–1) | 0 (0–1) | 0.77 |
Data are shown as either n (%) for categorical variables and mean ± standard deviation or median (IQR) for continuous variables. a: in both groups 14 infants were used for analysis. b: in both groups 10 infants were used for analysis. CHD congenital heart disease
Variables associated by low body perfusion and hypoxia for infants before NEC development
| NEC | n | Control | n | ||
|---|---|---|---|---|---|
| Apgar score at 1 minute a | 8 (7–8) | 12 | 9 (8–9) | 12 | 0.01 |
| Apgar score at 5 minutes a | 8 (8–9) | 12 | 9 (9–10) | 12 | 0.009 |
| Respiratory support in the delivery room (%) a | 11 (69) | 16 | 2 (13) | 16 | 0.001 |
| Diastolic blood pressure 0–24 h (mm Hg) a | 42 (34–44) | 16 | 40 (38–48) | 16 | 0.49 |
| Diastolic blood pressure 24–48 h (mm Hg)b | 39 (34–42) | 10 | 43 (37–51) | 10 | 0.11 |
| Systolic blood pressure 0–24 h (mm Hg) a | 68 (63–76) | 16 | 72 (66–77) | 16 | 0.37 |
| Systolic blood pressure 24–48 h (mm Hg)b | 67 (62–74) | 10 | 70 (68–80) | 10 | 0.29 |
| First Hb measurement (mmol/L)b | 9.3 (8.7–10.1) | 11 | 10.8 (9.1–11.6) | 11 | 0.26 |
| Lowest pH measurement a | 7.24 (7.17–7.35) | 9 | 7.38 (7.27–7.43) | 9 | 0.16 |
| Metabolic acidosis | 4 (44) | 9 | 2 (22) | 9 | 0.62 |
| Post-ductal SpO2 0–24 h a | 91 (89–96) | 13 | 93 (89–94) | 13 | 0.58 |
| Post-ductal SpO2 24–48 h b | 93 (89–95) | 12 | 93 (90–95) | 12 | 0.88 |
| Heart rate 0–24 h a | 143 (142–157) | 11 | 146 (134–154) | 11 | 0.49 |
| Heart rate 24–48 hb | 149 (138–155) | 8 | 140 (133–150) | 8 | 0.40 |
| Respiratory support 0–24 h (%) a | 9 (56) | 16 | 10 (63) | 16 | 0.70 |
| Respiratory support 24–48 h (%)b | 4 (50) | 8 | 4 (50) | 8 | 1.00 |
| Prostaglandin E1 0–24 h (%) a | 8 (50) | 16 | 11 (69) | 16 | 0.28 |
| Prostaglandin E1 24–48 h (%)b | 4 (44) | 9 | 5 (56) | 9 | 1.00 |
| Inotropes (%) a | 2 (13) | 16 | 1 (6) | 16 | 1.00 |
| Internal ductal diameter (mm) a | 2.8 (1.9–3.4) | 11 | 3.3 (3.0-3.6) | 11 | 0.17 |
| LA:Ao-ratio a | 1.7 (1.5–2.3) | 9 | 1.8 (1.4–1.9) | 9 | 0.51 |
| LVEDD (mm) a | 16.0 (11.2–20.0) | 10 | 15.5 (14.2–18.1) | 10 | 0.94 |
| Diastolic backflow in the descending aorta (%) a | 6 (55) | 11 | 5 (46) | 11 | 0.67 |
| Diastolic forward blood flow in the pulmonary arteries (%) a | 7 (70) | 10 | 7 (70) | 10 | 1.00 |
Data are shown as either n (%) for categorical variables and mean ± standard deviation or median (IQR) for continuous variables. a: Maximum of 16 infants used for the variable. b: Maximum of 13 infants used for the variable due to the development of NEC in 3 infants. LA:Ao-ratio: left atrium-aortic root ratio. LVEDD: Left ventricular end diastolic diameter